www.fdanews.com/articles/86271-hugin-news-ucb-transfers-back-to-recordati-the-rights-for-the-sale-of-corifeo
HUGIN NEWS/UCB TRANSFERS BACK TO RECORDATI THE RIGHTS FOR THE SALE OF CORIFEO
April 24, 2006
UCB (Nachrichten) announces that it has reached an
agreement with Recordati (Nachrichten) to transfer back the sales and marketing
rights in Germany of Corifeo, an antihypertensive calcium channel blocker, for
a payment to UCB of 10 million euros.
FinanzNachrichten.de